Back to search

Netherlands· NL-d66cc8c7c591

Emylif 50 mg orodispergeerbare film

A riluzole product containing riluzol, registered in Netherlands by Zambon S.p.A.. The same ATC class is registered in 17 of our 19 countries.

ATC N07XX02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedEmylif 50 mg orodispergeerbare filmATCN07XX02REGISTER NO.NL-d66cc8c7c591PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Riluzole is registered in 17 of 19 countries.

Countries holding a registration under ATC N07XX02 (riluzole), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose

Riluzole · ATC N07XX02

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of riluzole costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), the median price runs from $5.62 in France to $9.14 in Italy — a ×1.6 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Riluzole · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • IT Italy$9.14
  • CH Switzerland$8.63
  • FR France$5.62
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
RILUZOL
Manufacturer
Zambon S.p.A.
Country
Netherlands (NL)
ATC code
N07XX02
ATC class
Riluzole
Defined daily dose
0.1 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    128985

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

46 interactions on record for riluzole.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Riluzole · interactions on record

46 records

  • 4 severe
  • 28 moderate
  • 5 minor
  • 9 info

Most severe, free to view

  • LeflunomidL04AA13severe
  • TeriflunomidL04AA31severe
  • LeflunomideL04AK01severe
  • TeriflunomideL04AK02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Riluzole in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All riluzole products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Emylif, Riluzol Aristo
  • Belgium · Emylif, Riluzol Ab
  • Cyprus · Teglutik
  • Czechia · Riluzol Pmcs
  • Germany · Emylif, Glentek
  • Denmark · Emylif, Glentek
  • Estonia · Lizolorol, Rilustad
  • Spain · Emylif, Riluzol Aurovitas
  • Finland · Teglutik
  • France · Emylif, Riluzole Arrow
  • United Kingdom (Northern Ireland) · Emylif, Riluzole Accord Healthcare
  • Greece · Teglutik
  • Croatia · Alsemol
  • Hungary · Sclefic
  • Iceland · Emylif, Rilutek
  • Italy · Emylif, Riluzolo Aurobindo
  • Liechtenstein · Rilutek, Riluzole Zentiva
  • Luxembourg · Emylif, Teglutik
  • Norway · Emylif, Rilutek
  • Poland · Riluzol Pmcs, Riluzole Sun
  • Portugal · Emylif, Riluzol Aurovitas
  • Romania · Riluzol Pmcs
  • Sweden · Emylif, Glentek
  • Slovenia · Sclefic
  • Slovakia · Riluzol Pmcs

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a7488211-bb75-4ca8-8e97-ccdb5a2ed780
GET /v1/drugs/a7488211-bb75-4ca8-8e97-ccdb5a2ed780?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Orodispergeerbare film",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h128985_smpc.pdf",
  "strength": null,
  "atc_label": "Riluzole",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg128985",
  "excipients": [
    "BUTYLHYDROXYTOLUEEN (E 321)",
    "CITRAL",
    "CITROENOLIE",
    "CITROENSMAAKSTOF",
    "ETHANOL",
    "ETHANOL",
    "FRUCTOSE",
    "GLYCEROL (E 422)",
    "GLYCERYLMONO-OLEAAT",
    "HONINGSMAAKSTOF",
    "HYPROMELLOSE (E 464)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "MACROGOL 900000",
    "POLACRILINE",
    "PROPYLEENGLYCOL (E 1520)",
    "PROPYLEENGLYCOL (E 1520)",
    "PULLULAN (E 1204)",
    "SUCRALOSE (E 955)",
    "TITAANDIOXIDE (E 171)",
    "WITTE INKT",
    "XANTHAANGOM (E 415)",
    "XYLITOL (E 967)",
    "ZONNEGEEL FCF (E 110)"
  ],
  "substances": [
    "RILUZOL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h128985.pdf",
  "authorised_at": "2022/11/09",
  "procedure_number": "NL/H/5494/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "128985",
  "additional_monitoring": "N"
}

See everything about riluzole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.